個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Serum Institute of India (SII): Racing to Save Lives During a Pandemic
內容大綱
The CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how to temper his responsibility to meet the world's need for an affordable, efficacious and safe COVID-19 vaccine with his need to maintain profitability.